JAN (NYSE:JAN – Get Free Report) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks reports.
A number of other equities analysts also recently commented on JAN. Barclays lowered their price objective on JAN from $34.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 13th. Wall Street Zen upgraded shares of JAN from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Scotiabank raised their target price on shares of JAN from $31.00 to $33.00 and gave the company a “sector outperform” rating in a report on Thursday, September 17th. Weiss Ratings began coverage on shares of JAN in a report on Thursday, August 6th. They issued a “hold (c-)” rating on the stock. Finally, Cantor Fitzgerald lifted their price target on shares of JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, JAN currently has a consensus rating of “Moderate Buy” and an average price target of $32.31.
Check Out Our Latest Report on JAN
JAN Price Performance
JAN opened at $28.32 on Tuesday. JAN has a 12 month low of $22.76 and a 12 month high of $32.83. The business has a fifty day moving average price of $30.00 and a 200 day moving average price of $28.27.
JAN (NYSE:JAN – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.18). The business had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. The company’s quarterly revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Research analysts anticipate that JAN will post 0.97 EPS for the current year.
Institutional Trading of JAN
A number of hedge funds and other institutional investors have recently bought and sold shares of JAN. Engineers Gate Manager LP purchased a new stake in JAN during the 2nd quarter worth about $15,274,000. Wellington Management Group LLP acquired a new position in shares of JAN during the 2nd quarter worth about $8,739,000. WINTON GROUP Ltd purchased a new position in shares of JAN in the 2nd quarter valued at about $2,985,000. Readystate Asset Management LP purchased a new position in shares of JAN in the 2nd quarter valued at about $1,724,000. Finally, State of Alaska Department of Revenue raised its position in shares of JAN by 57.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock worth $1,082,000 after acquiring an additional 13,367 shares in the last quarter. 6.27% of the stock is currently owned by institutional investors and hedge funds.
More JAN News
Here are the key news stories impacting JAN this week:
- Neutral Sentiment: The most relevant available fundamental backdrop remains JAN’s latest quarterly report: earnings of $0.05 per share missed the $0.23 analyst consensus, although revenue of $216.46 million exceeded estimates and increased 45.4% year over year. Management maintained fiscal 2026 EPS guidance of $0.95 to $0.98, which may provide some support but does not eliminate concerns about profitability and the earnings shortfall.
About JAN
JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.
Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.
Read More
- Five stocks we like better than JAN
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
